 | Humanigen (OTCMKTS:HGEN) Trading 5.1% Higher
americanbankingnews.com - September 25 at 8:18 PM |
 | BioMedNewsBreaks – Humanigen Inc. (NASDAQ: HGEN) Secures $78.2M in Underwritten Public Offering - StreetInsider.com
streetinsider.com - September 25 at 1:40 PM |
| Humanigen (OTCMKTS:HGEN) Stock Price Down 9.8%
americanbankingnews.com - September 24 at 7:37 PM |
 | Humanigen inks manufacturing deal with Thermo Fisher for lenzilumab
seekingalpha.com - September 23 at 1:56 PM |
 | Humanigen Collaborates With Thermo Fisher To Expand Manufacturing Capacity For Lenzilumab - Nasdaq
nasdaq.com - September 23 at 8:55 AM |
 | Humanigen Announces Thermo Fisher Partnership to Expand Manufacturing for COVID-19 Therapeutic Candidate Lenzilumab - Business Wire
businesswire.com - September 23 at 8:55 AM |
| Humanigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Business Wire
businesswire.com - September 22 at 10:54 PM |
| Form 424B3 HUMANIGEN, INC - StreetInsider.com
streetinsider.com - September 22 at 5:49 PM |
 | Humanigen Announces Closing of Public Offering of Common Stock
finance.yahoo.com - September 22 at 5:49 PM |
| Humanigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
finance.yahoo.com - September 22 at 5:49 PM |
|
| Will Humanigen (NASDAQ:HGEN) Spend Its Cash Wisely? - Yahoo Finance
finance.yahoo.com - September 22 at 12:53 AM |
| Will Humanigen (NASDAQ:HGEN) Spend Its Cash Wisely?
finance.yahoo.com - September 21 at 2:52 PM |
| Form 8-K HUMANIGEN, INC For: Sep 17 - StreetInsider.com
streetinsider.com - September 21 at 9:50 AM |
 | Humanigen, Inc.: Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol "HGEN"
finanznachrichten.de - September 18 at 9:57 AM |
| Humanigen prices stock offering at $8.50
seekingalpha.com - September 18 at 9:57 AM |
| Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol "HGEN"
finance.yahoo.com - September 18 at 9:57 AM |
| Humanigen prices 8M-share IPO at $8.50 - Seeking Alpha
seekingalpha.com - September 18 at 4:57 AM |
| Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol “HGEN” - Business Wire
businesswire.com - September 17 at 11:50 PM |
| Humanigen, Inc.: Humanigen Announces Review of Lenzilumab Phase 3 Study in COVID-19 by Data Safety Monitoring Board
finanznachrichten.de - September 15 at 4:34 PM |
| Humanigen, Inc.: Humanigen Announces Proposed Public Offering of Common Stock and Subsequent Listing on NASDAQ
finanznachrichten.de - September 15 at 4:34 PM |
| Humanigen teams up with Lonza for COVID-19 candidate lenzilumab
seekingalpha.com - September 15 at 4:34 PM |
| Humanigen readies equity offering
seekingalpha.com - September 15 at 4:34 PM |
| Humanigen Inc. (HGEN) Announces Proposed 8M Share Common Offering; Reports Uplisting to NASDAQ - StreetInsider.com
streetinsider.com - September 15 at 11:34 AM |
| Humanigen Announces Proposed Public Offering of Common Stock and Subsequent Listing on Nasdaq - Business Wire
businesswire.com - September 15 at 11:34 AM |
| Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen's COVID-19 Therapeutic Candidate Lenzilumab - Business Wire
businesswire.com - September 15 at 6:33 AM |
| Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen's COVID-19 Therapeutic Candidate Lenzilumab
finance.yahoo.com - September 15 at 6:33 AM |
|
| Humanigen (OTCMKTS:HGEN) Reaches New 52-Week High at $10.94
americanbankingnews.com - September 14 at 10:52 PM |
| 2 No-Brainer Stocks to Buy in Biotech - Nasdaq
nasdaq.com - September 14 at 9:32 AM |
| Humanigen Announces Review of Lenzilumab Phase 3 Study in COVID-19 by Data Safety Monitoring Board - Business Wire
businesswire.com - September 14 at 9:32 AM |
| Humanigen Announces Review of Lenzilumab Phase 3 Study in COVID-19 by Data Safety Monitoring Board
finance.yahoo.com - September 14 at 9:32 AM |
| Humanigen (OTCMKTS:HGEN) Shares Scheduled to Reverse Split on Monday, September 14th
americanbankingnews.com - September 10 at 1:40 AM |
| Humanigen, Inc.: Humanigen Announces One-for-Five Reverse Stock Split; Reverse Split Facilitates Potential Uplisting to Nasdaq
finanznachrichten.de - September 5 at 9:22 AM |
| Humanigen to effect 1-for-5 reverse stock split - Seeking Alpha
seekingalpha.com - September 5 at 12:59 AM |
| Humanigen Announces One-for-Five Reverse Stock Split - Business Wire
businesswire.com - September 4 at 7:59 PM |
| Humanigen Announces One-for-Five Reverse Stock Split; Reverse Split Facilitates Potential Uplisting to Nasdaq
finance.yahoo.com - September 4 at 7:59 PM |
| Humanigen to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - September 2 at 11:50 PM |
| Humanigen, Inc.: Humanigen to Host Investor KOL Conference Call
finanznachrichten.de - September 2 at 8:36 AM |
| Humanigen to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 8:36 AM |
| Humanigen to Host Investor KOL Conference Call - Business Wire
businesswire.com - September 1 at 5:32 PM |
| Humanigen to Host Investor KOL Conference Call
finance.yahoo.com - September 1 at 5:32 PM |
| Humanigen's lenzilumab shows positive effect in COVID-19 in case-control study
seekingalpha.com - September 1 at 12:31 PM |
| Lenzilumab COVID-19 Case-Control Study Published in Mayo Clinic Proceedings Journal - Business Wire
businesswire.com - September 1 at 7:30 AM |
| Lenzilumab COVID-19 Case-Control Study Published in Mayo Clinic Proceedings Journal
finance.yahoo.com - September 1 at 7:30 AM |
| Humanigen Appoints Edward P. Jordan as Chief Commercial Officer - Business Wire
businesswire.com - August 24 at 9:32 AM |
| Seres Jumps On Data, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha.com - August 11 at 4:00 PM |
| Humanigen, Inc.: Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil
finanznachrichten.de - August 10 at 8:51 PM |
| Humanigen on go with COVID-19 study in Brazil
seekingalpha.com - August 10 at 8:51 PM |
| Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil - Business Wire
businesswire.com - August 10 at 3:50 PM |
| Marriott Posts Adj. Loss In Q2; Revenue Down 72% - Nasdaq
nasdaq.com - August 10 at 10:39 AM |
| Humanigen Expands Phase 3 Study Of Lenzilumab In COVID-19 To Brazil - Quick Facts - Nasdaq
nasdaq.com - August 10 at 10:39 AM |
